Kezar Life Sciences Inc. (KZR)
undefined
undefined%
At close: undefined
6.75
0.15%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -101.87M -68.24M -54.63M -41.74M -35.09M -23.17M -8.52M -8.99M
Depreciation & Amortization 1.07M 1.02M 1.51M 1.54M 1.30M 690.00K 175.00K 154.00K
Stock-Based Compensation 18.14M 14.01M 7.60M 4.94M 4.01M 1.99M 203.00K 128.00K
Other Working Capital -1.64M -6.27M 9.00K -2.32M -1.33M -1.38M -51.00K -583.00K
Other Non-Cash Items -3.68M -1.18M 91.00K 317.00K -979.00K -370.00K 472.00K 979.00K
Deferred Income Tax - - 1.77M - - - - -
Change in Working Capital 4.71M -4.46M 1.23M -2.01M 881.00K 62.00K 30.00K -1.05M
Operating Cash Flow -81.64M -58.85M -42.44M -36.95M -29.88M -20.79M -8.11M -9.76M
Capital Expenditures -1.81M -1.58M -316.00K -194.00K -607.00K -1.12M -389.00K -132.00K
Acquisitions - 89.81K 28.13K 56.30K -21.03K 10.00K - -
Purchase of Investments -180.40M -332.20M -156.38M -225.73M -102.25M -119.24M - -
Sales Maturities Of Investments 258.25M 242.39M 128.25M 169.42M 123.28M 36.45M - -
Other Investing Acitivies 5.00K -89.81K -28.13K -56.30K 21.03K 10.00K - -
Investing Cash Flow 76.05M -91.39M -28.44M -56.50M 20.42M -83.90M -389.00K -132.00K
Debt Repayment - - 9.53M - - - - -
Common Stock Repurchased - - - - - - - -
Dividend Paid - - - - - - - -
Other Financial Acitivies 638.00K 1.32M 2.08M 456.00K - - 49.76M 36.00K
Financial Cash Flow 638.00K 127.86M 112.58M 99.64M 272.00K 77.91M 49.76M 36.00K
Net Cash Flow -4.96M -22.43M 41.65M 6.28M -9.23M -26.86M 41.29M -10.01M
Free Cash Flow -83.45M -60.42M -42.75M -37.14M -30.48M -21.91M -8.50M -9.89M